UC HEALTH LINE: Chronic Fatigue Sufferers Need More Than Just Rest
Chronic fatigue syndromedefined by the Centers for Disease Control and Prevention (CDC) as extreme fatigue lasting at least six monthscan affect anyone no matter what age or gender, but is four times more common in women.
Lesley Arnold, MD, director of UCs Womens Health Research Program, treats chronic fatigue and conducts clinical trials using medications that may improve symptoms for those suffering from this often debilitating condition.
And,
We dont know what causes chronic fatigue, says
What we do know is that the majority of people with chronic fatigue go undiagnosed.
For anyone who thinks they may have chronic fatigue,
Medications, combined with non-drug therapies, such as stress reduction and improved diet, can help relieve symptoms of chronic fatigue,
For more information about the chronic fatigue research program and to learn about current clinical trials, call (513) 475-8113. To learn more about the Womens
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.